A1 Refereed original research article in a scientific journal

Single-label time-resolved luminescence assay for estrogen receptor-ligand binding




AuthorsHuttunen R, Shweta, Martikkala E, Lahdenranta M, Virta P, Hänninen P, Härmä H

Publication year2011

JournalAnalytical Biochemistry

Journal name in sourceAnalytical Biochemistry

Number in series1

Volume415

Issue1

First page 27

Last page31

Number of pages5

ISSN0003-2697

DOIhttps://doi.org/10.1016/j.ab.2011.03.038

Web address http://api.elsevier.com/content/abstract/scopus_id:79957713225


Abstract
Homogeneous luminescence-based microplate assays are desirable in high-throughput screening of new nuclear receptor regulators. Time-resolved fluorescence resonance energy transfer (TR-FRET) assays provide high sensitivity due to low background signal. The TR-FRET concept requires labeling of both ligand and receptor, making the assay format and its development relatively expensive and complex compared with single-label methods. To overcome the limitations of the multilabel methods, we have developed a single-label method for estrogen receptor (ER)-ligand binding based on quenching resonance energy transfer (QRET), where estradiol labeled with luminescent europium(III) chelate (Eu-E) is quenched using soluble quencher molecules. The luminescence signal of Eu-E on binding to full-length ER is protected from quenching while increasing competitor concentrations displace Eu-E from the receptor, reducing the signal. The QRET method was paralleled with a commercial fluorescence polarization (FP) assay. The measured signal-to-background (S/B) values for estradiol, estrone, fulvestrant, and tamoxifen obtained for the QRET assay (5.8-9.2) were clearly higher than the S/B values for the FP assay (1.3-1.5). A K value of 30 nM was calculated for binding of Eu-E to ER from a saturation binding isotherm. The QRET method provides an attractive new single-label assay format for nuclear receptor ligand screening. © 2011 Elsevier Inc. All rights reserved.



Last updated on 2024-26-11 at 12:35